ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Modified Calixarene Boosts DNA Delivery

September 22, 2008 | APPEARED IN VOLUME 86, ISSUE 38

[+]Enlarge
Guanidinium- functionalized calix[4]arene binds DNA and efficiently carries it inside ce
Guanidinium- functionalized calix[4]arene binds DNA and efficiently carries it inside ce

By changing the structure of a macrocyclic compound, researchers in Italy have created a more efficient type of reagent for transfection, which is the delivery of DNA or RNA into cells (Org. Lett., DOI: 10.1021/ol801326d). Genetic engineers use transfection reagents to alter a cell's gene expression and protein production. A team led by Francesco Sansone and Rocco Ungaro of the University of Parma reports preliminary studies showing that a formulation containing a calix[4]arene macrocycle delivers DNA more reliably than a commercially available transfection reagent. The team had previously modified the aromatic rings on calix[4]arenes with guanidinium groups, which are known to ferry compounds into cells. The macrocycles bound DNA, but they were inefficient at transfection and toxic to cells. In the team's new calix[4]arenes, the attachment points for the guanidinium moieties are hydroxyl groups, to good effect. The new reagents have low toxicity and efficiently transport DNA into a variety of cells. Traditional viral transfection agents can provoke an immune response, Sansone says. Lipid-based agents don't work in every type of cell, and most are poorly structurally characterized, impeding mechanistic studies aimed at improving them, he adds. The team now hopes to exploit calixarenes' synthetic flexibility to carry out such optimization studies.

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment